- Home
- CXAI vs EDSA Comparison
CXAI vs EDSA Comparison
Compare CXAI & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- EDSA
- Stock Information
- Founded
- CXAI N/A
- EDSA 2015
- Country
- CXAI United States
- EDSA Canada
- Employees
- CXAI N/A
- EDSA N/A
- Industry
- CXAI EDP Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CXAI Technology
- EDSA Health Care
- Exchange
- CXAI Nasdaq
- EDSA Nasdaq
- Market Cap
- CXAI 17.8M
- EDSA 17.5M
- IPO Year
- CXAI N/A
- EDSA N/A
- Fundamental
- Price
- CXAI $0.94
- EDSA $2.75
- Analyst Decision
- CXAI
- EDSA Strong Buy
- Analyst Count
- CXAI 0
- EDSA 2
- Target Price
- CXAI N/A
- EDSA $13.00
- AVG Volume (30 Days)
- CXAI 734.5K
- EDSA 116.5K
- Earning Date
- CXAI 11-11-2025
- EDSA 08-08-2025
- Dividend Yield
- CXAI N/A
- EDSA N/A
- EPS Growth
- CXAI N/A
- EDSA N/A
- EPS
- CXAI N/A
- EDSA N/A
- Revenue
- CXAI $6,005,000.00
- EDSA N/A
- Revenue This Year
- CXAI N/A
- EDSA N/A
- Revenue Next Year
- CXAI $60.00
- EDSA N/A
- P/E Ratio
- CXAI N/A
- EDSA N/A
- Revenue Growth
- CXAI N/A
- EDSA N/A
- 52 Week Low
- CXAI $0.61
- EDSA $1.55
- 52 Week High
- CXAI $2.54
- EDSA $4.49
- Technical
- Relative Strength Index (RSI)
- CXAI 63.61
- EDSA 62.87
- Support Level
- CXAI $0.79
- EDSA $2.47
- Resistance Level
- CXAI $0.88
- EDSA $2.82
- Average True Range (ATR)
- CXAI 0.05
- EDSA 0.18
- MACD
- CXAI 0.02
- EDSA 0.03
- Stochastic Oscillator
- CXAI 94.89
- EDSA 85.46
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.